Patent: 5,549,893
Summary for Patent: 5,549,893
| Title: | Use of protein C in the treatment of purpura fulminans |
| Abstract: | There is disclosed the use of protein C or activated protein C for preparing a drug useful for the maintenance and improvement of the microcirculation in patients suffering from circulatory disturbances, in particular with the proviso that the drug does not contain any immunoglobulin G. |
| Inventor(s): | Johann Eibl, Ludwig Pichler, Hans P. Schwarz |
| Assignee: | Oesterreichisches Institut fuer Haemoderivate |
| Application Number: | US08/429,462 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,549,893
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Takeda Pharmaceuticals U.s.a., Inc. | CEPROTIN | protein c concentrate (human) | For Injection | 125234 | March 30, 2007 | 5,549,893 | 2015-04-27 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
